Title The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease
Authors Kim, Hyun Kuk
Tantry, Udaya S.
Smith, Sidney C., Jr.
Jeong, Myung Ho
Park, Seung-Jung
Kim, Moo Hyun
Lim, Do-Sun
Shin, Eun-Seok
Park, Duk-Woo
Huo, Yong
Chen, Shao-Liang
Bo, Zheng
Goto, Shinya
Kimura, Takeshi
Yasuda, Satoshi
Chen, Wen-Jone
Chan, Mark
Aradi, Daniel
Geisler, Tobias
Gorog, Diana A.
Sibbing, Dirk
Lip, Gregory Y. H.
Angiolillo, Dominick J.
Gurbel, Paul A.
Jeong, Young-Hoon
Affiliation Chosun Univ Hosp, Dept Cardiol, Gwangju, South Korea
Sinai Hosp Baltimore, Sinai Ctr Thrombosis Res, Baltimore, MD USA
Univ N Carolina, Div Cardiol, Chapel Hill, NC USA
Chonnam Natl Univ Hosp, Dept Cardiol, Gwangju, South Korea
Univ Ulsan, Heart Inst, Asan Med Ctr, Seoul, South Korea
Dong A Univ Hosp, Dept Cardiol, Busan, South Korea
Korea Univ, Dept Cardiol, Cardiovasc Ctr, Anam Hosp, South, Seoul, South Korea
Ulsan Hosp, Div Cardiol, Ulsan, South Korea
Peking Univ First Hosp, Dept Cardiol, Beijing, Peoples R China
Nanjing Med Univ, Nanjing First Hosp, Cardiovasc Dept, Nanjing, Peoples R China
Tokai Univ, Sch Med, Dept Med Cardiol, Tokai, Kanagawa, Japan
Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan
Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan
Natl Taiwan Univ Hosp, Cardiol Div, Dept Internal Med, Taipei, Taiwan
Natl Univ Heart Ctr Singapore, Dept Cardiol, Singapore, Singapore
Semmelweis Univ, Heart Ctr Balatonfured, Budapest, Hungary
Semmelweis Univ, Heart & Vasc Ctr, Budapest, Hungary
Univ Hosp Tubingen, Dept Cardiol & Cardiovasc Med, Tubingen, Germany
Imperial Coll, Natl Heart & Lung Inst, London, England
Univ Hertfordshire, Postgrad Med Sch, Hatfield, Herts, England
LMU Munchen, Dept Cardiol, Munich, Germany
DZHK German Ctr Cardiovasc Res, Munich Heart Alliance, Partner Site, Munich, Germany
Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England
Univ Liverpool, Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England
Univ Florida, Coll Med, Div Cardiol, Jacksonville, FL USA
Gyeongsang Natl Univ, Sch Med & Cardiovasc Ctr, Dept Internal Med, Changwon Hosp, Chang Won, South Korea
Gyeongsang Natl Univ, Inst Hlth Sci, Jinju, South Korea
Keywords PERCUTANEOUS CORONARY INTERVENTION
CLOPIDOGREL PLATELET REACTIVITY
EXPERT CONSENSUS STATEMENT
DUAL ANTIPLATELET THERAPY
CAROTID-ARTERY-DISEASE
ATRIAL-FIBRILLATION
RACIAL-DIFFERENCES
CLINICAL-OUTCOMES
STENT THROMBOSIS
MYOCARDIAL-INFARCTION
Issue Date Apr-2021
Publisher THROMBOSIS AND HAEMOSTASIS
Abstract East Asian patients have reduced anti-ischemic benefits and increased bleeding risk during antithrombotic therapies compared with Caucasian patients. As potent P2Y (12) receptor inhibitors (e.g., ticagrelor and prasugrel) and direct oral anticoagulants are commonly used in current daily practice, the unique risk-benefit trade-off in East Asians has been a topic of emerging interest. In this article, we propose updated evidence and future directions of antithrombotic treatment in East Asian patients.
URI http://hdl.handle.net/20.500.11897/621727
ISSN 0340-6245
DOI 10.1055/s-0040-1718729
Indexed SCI(E)
Appears in Collections: 第一医院

Files in This Work
There are no files associated with this item.

Web of Science®


0

Checked on Last Week

Scopus®



Checked on Current Time

百度学术™


0

Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.